CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17 - Archive ouverte HAL Access content directly
Journal Articles Cell Reports Medicine Year : 2020

CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17

(1, 2) , (1, 2) , (2) , (3) , (1, 2) , (1, 2) , (1, 2) , (1, 2) , (4, 2) , (2) , (1, 2) , (2) , (1, 2, 5) , (5) , (6) , (7) , (8) , (1, 2) , (2) , (1, 2) , (9) , (1, 2)
1
2
3
4
5
6
7
8
9
Nathalie Droin
Olaf Mercier

Abstract

Accumulation of CD103+CD8+ resident memory T (TRM) cells in human lung tumors has been associated with a favorable prognosis. However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established. Using quantitative multiplex immunofluorescence on cohorts of non-small cell lung cancer patients treated with anti-PD-(L)1, we show that an increased density of CD103+CD8+ lymphocytes in immunotherapy-naive tumors is associated with greatly improved outcomes. The density of CD103+CD8+ cells increases during immunotherapy in most responder, but not in non-responder, patients. CD103+CD8+ cells co-express CD49a and CD69 and display a molecular profile characterized by the expression of PD-1 and CD39. CD103+CD8+ tumor TRM, but not CD103-CD8+ tumor-infiltrating counterparts, express Aiolos, phosphorylated STAT-3, and IL-17; demonstrate enhanced proliferation and cytotoxicity toward autologous cancer cells; and frequently display oligoclonal expansion of TCR-β clonotypes. These results explain why CD103+CD8+ TRM are associated with better outcomes in anti-PD-(L)1-treated patients.
Fichier principal
Vignette du fichier
S2666379120301695.pdf (3.09 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03492631 , version 1 (24-10-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Stéphanie Corgnac, Ines Malenica, Laura Mezquita, Edouard Auclin, Elodie Voilin, et al.. CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17. Cell Reports Medicine, 2020, 1, pp.100127 -. ⟨10.1016/j.xcrm.2020.100127⟩. ⟨hal-03492631⟩
10 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More